These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 26917533)
1. [Bioinformatics analysis on molecular mechanism of ribavirin and interferon-α in treating MERS-CoV]. Zheng Y; Wang QY Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):291-3. PubMed ID: 26917533 [TBL] [Abstract][Full Text] [Related]
2. Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia. Khalid M; Khan B; Al Rabiah F; Alismaili R; Saleemi S; Rehan-Khaliq AM; Weheba I; Al Abdely H; Halim M; Nadri QJ; Al Dalaan AM; Zeitouni M; Butt T; Al Mutairy E Ann Saudi Med; 2014; 34(5):396-400. PubMed ID: 25827696 [TBL] [Abstract][Full Text] [Related]
3. Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases. Khalid M; Al Rabiah F; Khan B; Al Mobeireek A; Butt TS; Al Mutairy E Antivir Ther; 2015; 20(1):87-91. PubMed ID: 24831606 [TBL] [Abstract][Full Text] [Related]
4. IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study. Shalhoub S; Farahat F; Al-Jiffri A; Simhairi R; Shamma O; Siddiqi N; Mushtaq A J Antimicrob Chemother; 2015 Jul; 70(7):2129-32. PubMed ID: 25900158 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome. Kim UJ; Won EJ; Kee SJ; Jung SI; Jang HC Antivir Ther; 2016; 21(5):455-9. PubMed ID: 26492219 [TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes among hospital patients with Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Habib AMG; Ali MAE; Zouaoui BR; Taha MAH; Mohammed BS; Saquib N BMC Infect Dis; 2019 Oct; 19(1):870. PubMed ID: 31640578 [TBL] [Abstract][Full Text] [Related]
7. Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. Omrani AS; Saad MM; Baig K; Bahloul A; Abdul-Matin M; Alaidaroos AY; Almakhlafi GA; Albarrak MM; Memish ZA; Albarrak AM Lancet Infect Dis; 2014 Nov; 14(11):1090-1095. PubMed ID: 25278221 [TBL] [Abstract][Full Text] [Related]
8. Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Al-Tawfiq JA; Memish ZA Expert Rev Anti Infect Ther; 2017 Mar; 15(3):269-275. PubMed ID: 27937060 [TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Momattin H; Al-Ali AY; Al-Tawfiq JA Travel Med Infect Dis; 2019; 30():9-18. PubMed ID: 31252170 [TBL] [Abstract][Full Text] [Related]
11. Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study. Al-Tawfiq JA; Momattin H; Dib J; Memish ZA Int J Infect Dis; 2014 Mar; 20():42-6. PubMed ID: 24406736 [TBL] [Abstract][Full Text] [Related]
12. Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques. Falzarano D; de Wit E; Rasmussen AL; Feldmann F; Okumura A; Scott DP; Brining D; Bushmaker T; Martellaro C; Baseler L; Benecke AG; Katze MG; Munster VJ; Feldmann H Nat Med; 2013 Oct; 19(10):1313-7. PubMed ID: 24013700 [TBL] [Abstract][Full Text] [Related]
13. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. Lee JY; Kim YJ; Chung EH; Kim DW; Jeong I; Kim Y; Yun MR; Kim SS; Kim G; Joh JS BMC Infect Dis; 2017 Jul; 17(1):498. PubMed ID: 28709419 [TBL] [Abstract][Full Text] [Related]